This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

ALC - Alcidion Group

Jump to new
You can say with a pretty high degree of confidence that the bottom is in for Alcidion Group, at least for now. It has risen from 3.9c earlier this month to a high of 7.6c on 20 March, but it is now far too late to add it to The bottom is in! thread. This train has well and truly left the station.

On 18 March it announced to the market that it has won a major contract with Dartford and Gravesham NHS Trust in the UK, under which Alcidion will deploy the first Miya Precision, Patientrack and Smartpage installation outside of Australia. The five year contract is valued at £1.16 million (~$2.1million).

On 21 March ALC further announced that it has been selected as the strategic solution partner for Brighton and Sussex University Hospitals NHS Trust in the UK, under which Alcidion will implement its Patientrack technology solution.

Clearly, ALC is making ground in the UK and the recent positive sentiment towards the company is no doubt based largely on the potential that market holds for ALC.

On that basis alone, Alcidion Group is definitely a stock to watch in 2019.

 
Alcidion Group pushing through 8c this morning. The release of the company's Q3 FY2019 report on Tuesday has been the catalyst for more buying with volume increasing substantially since the announcement.

24 contracts signed or renewed in the last quarter with revenue increasing and a net operating cash surplus of $1.3 million. ALC looks well positioned for more growth and management has confirmed that there is no need for a capital raising to restore working capital.

I think this one will see further share price growth this year if the good news continues. It's currently up another 10.5% to 8.4c this morning.

 
Alcidion Group hitting a high of 10c today. Largest daily volume in more than 12 months.

Director Katrina Elizabeth Doyle picked up 2 million shares on market on 26 April. See Change of Director's Interest Notice dated 29 April.

That's a big vote of confidence in the future of ALC.
 
This "health Informatics Company" as they describe themselves have been making healthy gains this year as they continue to make shareholders happy. The recent quarterly marks a positive cash flow and a better future with new contracts signed providing near term growth.
Alcidon expect FY19 revenue to be between $16.5M to $16.9M subject to any final year -end adjustments, which is approximately four times the $4.2M Alcidion Group revenue in FY18.
The company signed 23 new contracts during the quarter. If their sales team keep this up Alcidon are looking forward to a bright future.
 
Alcidion had its run in 2019 but news was hard to find, so it lost its shine. Like many in the data and analytics side of healthcare, product is plentiful:
- software products (in ALC case, Miya, Patientrack and Smartpage),
- reselling of selected healthcare software products from its strategic partners and
- delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers.

Who can argue against "solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes", but contracts let alone the big breakthrough is tough. Up against Big Healthcare multinationals on one hand and health system budget managers on the other.

Picking up a few contracts along the way, but the quantum is usually , $1million, and usually for a short period 1-2 years max.

Today, a bit of a twist, that may work for them with the inner west Local Health District
 
likely to lift today, this NHS contract is larger and more comprehensive than earlier nibbles:

Highlights
• ALC has signed its largest ever Miya Precision contract representing $9.5M TCV over 5 years
• Second NHS trust to procure both Miya Precision and Better OPENeP solution in the last year
• With $5.48M of TCV to be booked in FY21 from this contract, total revenue now sits at $20.2M able to be recognised in FY21 – vs $18.6M in FY20 with 7 months of the year remaining
 
Key Highlights:
• Alcidion’s reseller agreement with NextGate now expanded to include United Kingdom and Ireland.
• Expansion strengthens competitive position in UK market as NHS transitions to digitised healthcare solutions and integrated care records.

 
It's been a great six months for ALC. It has been one good announcement after another beginning with the 9 November 2020 announcement that it had signed a 9.5M deal with South Tees Hospitals NHS Foundation Trust for Miya Precision suite & ePMA.

Today ALC announced that it has acquired ExtraMed Ltd, a leading UK provider of patient flow management software with nine NHS Trusts, six of which are new customers for Alcidion.


They are making huge inroads into the UK market and look to be a solid long term investment. If they can maintain their current rate of growth, I can see them possibly hitting $1 by the end of 2021, especially if they look like achieving their goal of breakeven in FY2022.

 
Been a good pick me up..ALC Nearly went past the radar Alcidion Group, look like there in a good position to move forward, fundamentally strong, poised to strike...

https://www.alcidion.com/

 
Healthcare informatics company Alcidion (ALC) is set to raise $55 million, priced at 25¢ per share, to fund the acquisition of UK patient administration software (PAS) company Silverlink. The acquisition extends Alcidion’s capability into PAS and is fitting with its vision of becoming a cloud-based modular electronic patient record.

Silverlink services the UK’s National Health Service and has forecast $7.8 million revenue from existing contracts for the year to 30 April, 2022 and EBITDA of $4.8 million.

It’s the second UK-based acquisition Alcidion has made in the last nine months, having also acquired patient flow management software company ExtraMed in April.

(ALC made it to 48c in June; now 32c.)
 
Bought into this at 36c 3 months ago thinking it would head north again, but no, I'm down 25%.
With its foray into overseas markets continuing, I can only see one way now. I have tipped ALC
in the FCY2022 Comp.
 
Big retracement with the large cap raising My pick in 2022 comp.

Like the exposure to the healthcare sector and acquisition should increase earnings significantly
 
Maybe turning the corner?

Highlights:
- FY22Q4 positive operating cashflow of $3.3M
o Record quarterly cash receipts of $14.0M

- FY22 full year positive operating cashflow of $1.0M
o FY22 operating cashflow of $3.1M, excluding one-off M&A costs of $2.1M
o FY22 cash receipts of $41.4M, up 29% on pcp (prior corresponding period)

- Unaudited FY22 revenue of $34.0M, up 31% on pcp

- FY22 new sales with Total Contract Value (TCV) of $57.7M, up 96% on pcp
o New TCV sales in Q4 of $14.8M, with $2.7M recognised in FY22

- Positive unaudited underlying FY22 EBITDA (excluding M&A costs)

- Opening balance of contracted revenue to be recognised in FY23 of $28.3M, up 87% on pcp
o Further $2.9M of scheduled renewal revenue expected to be recognised in FY23

- Cash balance of $17.3M at 30 June 2022
 

Alcidion (ASX:ALC) signs three-year deal with UHS trust for Miya Precision IT platform

Alcidion (ASX:ALC) has signed a three-year agreement with the University Hospital Southampton NHS Foundation Trust (UHS) to implement its Miya Precision IT platform.
themarketherald.com.au
Alcidion (ALC) has signed a three-year agreement with the University Hospital Southampton NHS Foundation Trust (UHS) to implement its Miya Precision IT platform.

The $2.8 million contract will see the company deliver a modern, modular electronic patient record, using a combination of Miya modules and UHS incumbent products.

In addition, Alcidion will become a supplier of some of UHS’s intellectual property, including the Hospital Integrated Clinical Support System (HICSS), which manages the scheduling and reporting of endoscopy procedures.

Live price chart: https://uk.advfn.com/p.php?pid=staticchart&s=ASX^ALC&p=5&t=1
 
Dona Ferentes said:
Maybe turning the corner?
Click to expand...
n maybe not.

ighlights:
• H1’24 revenue of $19.1M, in-line with pcp; 74% recurring revenue
• Gross profit of $16.7M, representing 87.8% gross profit margin
• EBITDA loss of $2.9M (H1’23: ($1.2M))
• FY24 contracted revenue as of 31 December of $35.5M, up 4% on pcp
• $24.3M of new contracted sales in 1H’24
o $23.3M South Tees contract extension ($20.5m included in new contracted sales) for additional 8 years (to 2033) for Miya Precision EPR, with further upside potential
o Additional new sales of $3.8M
• Annualised cost savings of $6.4M currently being implemented primarily via reduction in employee expenses
• Realigned cost base will not impact ability to win larger contracts and service existing customers which remain a key part of the future growth profile
• As a result of the costs savings, expect H2’24 operating cashflow to be positive
• In the absence of larger contract wins (which are progressing but timing unpredictable), expect to achieve H2’24 revenue similar to H1’24
• $126M of sold and renewal revenue already committed over the next five years (excl. FY24)
• Cash balance of $7.9M and no debt at 31 December 2023, strengthened further by receipt of $3.9M in early January 2024.

are we there yet?

.
contract wins / grounding day?
 
off its lows, a 30 per cent lift ... to 7.1c
.
Alcidion Selected as Preferred EPR Supplier by North Cumbria
- North Cumbria Integrated Care NHS Foundation Trust has selected Alcidion as the preferred supplier for its new Electronic Patient Record (EPR) system
- Preferred supplier selection follows a competitive tender process
- Subject to successful negotiation it is anticipated to be a 10-year contract utilising the full Miya Precision product suite along with partner applications
- Total Contract Value under negotiation; likely to be in the range of A$30-40M over 10 years depending on modules included
- Upon finalising the contract, Alcidion is targeting deployment in Q3 Financial Year 2025 (Jan-March)
- NCIC is an existing Alcidion customer, using our Patient Administration System (Silverlink PCS) which played a key role in addressing functional requirements
 
You must log in or register to reply here.

Similar threads

GHM - Golden Horse Minerals
Replies
3
Views
802
Dona Ferentes
MHM - Mount Hope Mining
Replies
2
Views
811
Dona Ferentes
CGR - CGN Resources
Replies
7
Views
3K
Dona Ferentes
GGR - Golden Globe Resources
Replies
2
Views
1K
System
MAC - Mac Copper
Replies
16
Views
3K
peter2
Menu
Log in
Register
Cookies are required to use this site. You must accept them to continue using the site. Learn more...